The patient was preoxygenated and sodium thiopentone 375 mg and suxamethonium chloride 75 mg given intravenously. Cricoid pressure was applied and an endotracheal tube inserted followed by intermittent positive pressure ventilation with a gaseous 2: 1 mixture of nitrous oxide and oxygen together with methoxyflurane.
The procedure finished within half an hour but there was no return of muscle tone. After a further 20 minutes slight spontaneous respirations reappeared. As the respiration gradually improved assistance was withdrawn. The administration of anaesthesia was ceased one hour after injection of suxamethonium. Serum was sent for a plasma cholinesterase estimation the next day and it was found to be low. After three months a further blood sample was examined together with samples from the patient's father, mother, brother and three sisters, all of whom were healthy. It was not possible to test other members of the father's family. The cholinesterase level as well as dibucaine and fluoride numbers were measured by the method proposed by the Association of Clinical Biochemists. 4 The results (shown in Table 1 ) indicate that the father and all his daughters are heterozygous for the silent gene. The proposed genetic tree is shown in Figure 1 . 
DISCUSSION
This patient had two reasons for her low cholinesterase level at the time of operation. Pregnancy at term is associated with a fall in cholinesterase activity to approximately 70070 of normal. 5 She is also heterozygous for the silent gene which results in lowered cholinesterase activity.6 The combination of these two factors probably resulted in her sensitivity to suxamethonium chloride. When tested three months post partum she still had the lowest cholinesterase activity of the family. This may be a reflection of her recent pregnancy. The period of cholinesterase depression following pregnancy is not exactly known but levels usually return to the non-pregnant level between ten days and six weeks post partum. 3 The incidence of postanaesthetic apnoea following the administration of suxamethonium-like drugs in patients heterozygous for the silent gene is not accurately known. Some state it to be in the order of one in a thousand 3 while others suggest a slightly higher incidence. 6 The possibility of sensitivity occurring in a patient will be increased if they also have other factors contributing to a low cholinesterase level, as was the case in this pregnant patient.
As far as can be ascertained this is the first Australian family to be reported with the silent cholinesterase gene. However, the incidence of this variant is relatively frequent at around one in two hundred people. 3 Several other families with this condition have been identified by The Royal Melbourne Hospital Biochemistry Department.
